![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
1. After oral dosing with a new racemic dihydropyridine calcium channel blocker (I), plasma levels of (±)-I, the 3-desisopropyl metabolite (M-2), the pyridine metabolite (M-3) and the 5-desmethyl metabolite (M-10) in female rats were higher than in males, and plasma levels of (+)-I were higher than those of the (—)-enantiomer in both sexes.
2. Plasma levels of M-2 after oral dosing with (—)-I were much higher than those after dosing with (+)-I, in both male and female rats.
3. Stereoselective metabolism of I by rat liver microsomes was shown in the formation of the 3-(2′-hydroxy-1′-methylethyl) ester metabolite (M-1), and metabolites M-2 and M-10.
4. Marked sex differences were seen in the formation of M-1 and M-3 in adult rats (7 weeks of age), but not in immature rats (3 weeks of age).
5. In liver microsomes of rats pretreated with phenobarbital, the formation of M-1 was decreased in adult male rats, and formation of M-2 and M-3 was increased in adult rats of both sexes.